Keywords
Last Name
Institution

ALAN J GARBER

TitleProfessor
InstitutionBaylor College of Medicine
DepartmentDepartment of Medicine
Address6620 Main Street
Houston TX 77030
vCardDownload vCard
    Other Positions
    TitleProfessor
    InstitutionBaylor College of Medicine
    DepartmentDepartment of Biochemistry & Molecular Biology
    DivisionBiochemistry & Molecular Biology

    TitleProfessor
    InstitutionBaylor College of Medicine
    DepartmentDepartment of Molecular & Cellular Biology
    DivisionMolecular & Cellular Biology


    Collapse Additional Tools and Researcher Information 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Garvey WT, Mechanick JI, Brett EM, Garber AJ, Hurley DL, Jastreboff AM, Nadolsky K, Pessah-Pollack R, Plodkowski R. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITYEXECUTIVE SUMMARYComplete Guidelines available at https://www.aace.com/publications/guidelines. Endocr Pract. 2016 Jul; 22(7):842-84. PMID: 27472012.
      View in: PubMed
    2. Samson SL, Garber AJ. Prevention of type 2 Diabetes Mellitus: Potential of pharmacological agents. Best Pract Res Clin Endocrinol Metab. 2016 Jun; 30(3):357-71. PMID: 27432071.
      View in: PubMed
    3. Handelsman Y, Henry RR, Bloomgarden ZT, Dagogo-Jack S, DeFronzo RA, Einhorn D, Ferrannini E, Fonseca VA, Garber AJ, Grunberger G, LeRoith D, Umpierrez GE, Weir MR. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON THE ASSOCIATION OF SGLT-2 INHIBITORS AND DIABETIC KETOACIDOSIS. Endocr Pract. 2016 Jun; 22(6):753-62. PMID: 27082665.
      View in: PubMed
    4. Garvey WT, Mechanick JI, Brett EM, Garber AJ, Hurley DL, Jastreboff AM, Nadolsky K, Pessah-Pollack R, Plodkowski R. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITY. Endocr Pract. 2016 Jul; 22 Suppl 3:1-203. PMID: 27219496.
      View in: PubMed
    5. Garber AJ, Abrahamson MJ, Barzilay JI, Blonde L, Bloomgarden ZT, Bush MA, Dagogo-Jack S, DeFronzo RA, Einhorn D, Fonseca VA, Garber JR, Garvey WT, Grunberger G, Handelsman Y, Henry RR, Hirsch IB, Jellinger PS, McGill JB, Mechanick JI, Rosenblit PD, Umpierrez GE. CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2016 EXECUTIVE SUMMARY. Endocr Pract. 2016 Jan; 22(1):84-113. PMID: 26731084.
      View in: PubMed
    6. Garber AJ, Abrahamson MJ, Barzilay JI, Blonde L, Bloomgarden ZT, Bush MA, Dagogo-Jack S, Davidson MB, Einhorn D, Garber JR, Garvey WT, Grunberger G, Handelsman Y, Hirsch IB, Jellinger PS, McGill JB, Mechanick JI, Rosenblit PD, Umpierrez GE. CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2015 EXECUTIVE SUMMARY. Endocr Pract. 2015 Dec; 21(12):1403-14. PMID: 26642101.
      View in: PubMed
    7. Gilbert MP, Marre M, Holst JJ, Garber A, Baeres FM, Thomsen H, Pratley RE. COMPARISON OF THE LONG-TERM EFFECTS OF LIRAGLUTIDE AND GLIMEPIRIDE MONOTHERAPY ON BONE MINERAL DENSITY IN PATIENTS WITH TYPE 2 DIABETES. Endocr Pract. 2016 Apr; 22(4):406-11. PMID: 26574791.
      View in: PubMed
    8. Grunberger G, Bailey T, Camacho PM, Einhorn D, Garber AJ, Handelsman Y, Harrell RM, Lando HM, Law B, Leffert JD, Orzeck EA. Proceedings from the american association of clinical endocrinologists and american college of endocrinology consensus conference on glucose monitoring. Endocr Pract. 2015 May; 21(5):522-33. PMID: 25962091.
      View in: PubMed
    9. Garber AJ, Abrahamson MJ, Barzilay JI, Blonde L, Bloomgarden ZT, Bush MA, Dagogo-Jack S, Davidson MB, Einhorn D, Garber JR, Garvey WT, Grunberger G, Handelsman Y, Hirsch IB, Jellinger PS, McGill JB, Mechanick JI, Rosenblit PD, Umpierrez G, Davidson MH. Aace/Ace comprehensive diabetes management algorithm 2015. Endocr Pract. 2015 Apr 2; 21(4):438-47. PMID: 25877012.
      View in: PubMed
    10. Handelsman Y, Bloomgarden ZT, Grunberger G, Umpierrez G, Zimmerman RS, Bailey TS, Blonde L, Bray GA, Cohen AJ, Dagogo-Jack S, Davidson JA, Einhorn D, Ganda OP, Garber AJ, Garvey WT, Henry RR, Hirsch IB, Horton ES, Hurley DL, Jellinger PS, Jovanovi? L, Lebovitz HE, LeRoith D, Levy P, McGill JB, Mechanick JI, Mestman JH, Moghissi ES, Orzeck EA, Pessah-Pollack R, Rosenblit PD, Vinik AI, Wyne K, Zangeneh F. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY--CLINICAL PRACTICE GUIDELINES FOR DEVELOPING A DIABETES MELLITUS COMPREHENSIVE CARE PLAN--2015--EXECUTIVE SUMMARY. Endocr Pract. 2015 Apr; 21(4):413-37. PMID: 27408942.
      View in: PubMed
    11. Garber AJ. ANTI-OBESITY PHARMACOTHERAPY AND THE POTENTIAL FOR PREVENTING PROGRESSION FROM PREDIABETES TO TYPE 2 DIABETES. Endocr Pract. 2015 Jun; 21(6):634-44. PMID: 25716632.
      View in: PubMed
    12. Garber AJ. What is the best approach to glycaemic control in patients with type 2 diabetes? Diabetes Obes Metab. 2015 Feb; 17(2):105-6. PMID: 25359422.
      View in: PubMed
    13. Garber AJ. Biosimilar products are not bioidentical. J Diabetes. 2015 Mar; 7(2):153-4. PMID: 25395269.
      View in: PubMed
    14. Grunberger G, Garber AJ, Mechanick JI. Obesity management: applying clinical trial data to clinical care. Endocr Pract. 2014 Dec; 20 Suppl 2:6-19. PMID: 25526732.
      View in: PubMed
    15. Hollander P, King AB, Del Prato S, Sreenan S, Balci MK, Muñoz-Torres M, Rosenstock J, Hansen CT, Niemeyer M, Garber AJ. Insulin degludec improves long-term glycaemic control similarly to insulin glargine but with fewer hypoglycaemic episodes in patients with advanced type 2 diabetes on basal-bolus insulin therapy. Diabetes Obes Metab. 2015 Feb; 17(2):202-6. PMID: 25387855.
      View in: PubMed
    16. Garvey WT, Garber AJ, Mechanick JI, Bray GA, Dagogo-Jack S, Einhorn D, Grunberger G, Handelsman Y, Hennekens CH, Hurley DL, McGill J, Palumbo P, Umpierrez G. American association of clinical endocrinologists and american college of endocrinology consensus conference on obesity: building an evidence base for comprehensive action. Endocr Pract. 2014 Sep; 20(9):956-76. PMID: 25253226.
      View in: PubMed
    17. Mechanick JI, Camacho PM, Garber AJ, Garber JR, Pessah-Pollack R, Petak SM, Tangpricha V, Trence DL. American Association of Clinical Endocrinologists and American College of Endocrinology Protocol for Standardized Production of Clinical Practice Guidelines, Algorithms, and Checklists - 2014 Update and the AACe G4G Program. Endocr Pract. 2014 Jul; 20(7):692-702. PMID: 25057098.
      View in: PubMed
    18. Hennekens CH, Pfeffer MA, Newcomer JW, Jellinger PS, Garber A. Treatment of diabetes mellitus: the urgent need for multifactorial interventions. Am J Manag Care. 2014 May; 20(5):357-9. PMID: 25181565.
      View in: PubMed
    19. Garber AJ, Einhorn D, Mechanick JI. AACE Response to viewpoint of December 9, 2013. JAMA Intern Med. 2014 May; 174(5):827. PMID: 24799016.
      View in: PubMed
    20. Bach RG, Brooks MM, Lombardero M, Genuth S, Donner TW, Garber A, Kennedy L, Monrad ES, Pop-Busui R, Kelsey SF, Frye RL. Response to letter regarding article, "rosiglitazone and outcomes for patients with diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial". Circulation. 2014 Apr 22; 129(16):e460-1. PMID: 24753557.
      View in: PubMed
    21. Samson SL, Garber AJ. Metabolic syndrome. Endocrinol Metab Clin North Am. 2014 Mar; 43(1):1-23. PMID: 24582089.
      View in: PubMed
    22. Garber AJ. GLP-1 receptor agonists: why is once weekly inferior to once daily? Lancet Diabetes Endocrinol. 2014 Apr; 2(4):266-7. PMID: 24703036.
      View in: PubMed
    23. Garber AJ. The importance of incretin therapies for managing type 2 diabetes. Lancet Diabetes Endocrinol. 2014 Feb; 2(2):95-7. PMID: 24622701.
      View in: PubMed
    24. Garber AJ. Will the next generation of basal insulins offer clinical advantages? Diabetes Obes Metab. 2014 Jun; 16(6):483-91. PMID: 24118819.
      View in: PubMed
    25. Garber AJ, Newcomer JW, Hennekens CH. Lower A1c targets in type 2 diabetes and increased mortality: causal or casual? Am J Med. 2013 Dec; 126(12):1033-4. PMID: 24035125.
      View in: PubMed
    26. Bach RG, Brooks MM, Lombardero M, Genuth S, Donner TW, Garber A, Kennedy L, Monrad ES, Pop-Busui R, Kelsey SF, Frye RL. Rosiglitazone and outcomes for patients with diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial. Circulation. 2013 Aug 20; 128(8):785-94. PMID: 23857320; PMCID: PMC3816149.
    27. Handelsman Y, Leroith D, Bloomgarden ZT, Dagogo-Jack S, Einhorn D, Garber AJ, Grunberger G, Harrell RM, Gagel RF, Lebovitz HE, McGill JB, Hennekens CH. Diabetes and cancer--an AACE/ACE consensus statement. Endocr Pract. 2013 Jul-Aug; 19(4):675-93. PMID: 23978590.
      View in: PubMed
    28. Tamez-Pérez HE, Proskauer-Peña SL, Hern?ndez-Coria MI, Garber AJ. AACE Comprehensive Diabetes Management Algorithm 2013. Endocrine Practice. Endocr Pract. 2013 Jul-Aug; 19(4):736-7. PMID: 23807530.
      View in: PubMed
    29. Garber AJ. In response. Endocr Pract. 2013 Jul-Aug; 19(4):737. PMID: 24137733.
      View in: PubMed
    30. Garber AJ. Treat-to-target trials: uses, interpretation and review of concepts. Diabetes Obes Metab. 2014 Mar; 16(3):193-205. PMID: 23668598; PMCID: PMC4237121.
    31. Philis-Tsimikas A, Del Prato S, Satman I, Bhargava A, Dharmalingam M, Skjøth TV, Rasmussen S, Garber AJ. Effect of insulin degludec versus sitagliptin in patients with type 2 diabetes uncontrolled on oral antidiabetic agents. Diabetes Obes Metab. 2013 Aug; 15(8):760-6. PMID: 23577643; PMCID: PMC3799217.
    32. Garber AJ, Abrahamson MJ, Barzilay JI, Blonde L, Bloomgarden ZT, Bush MA, Dagogo-Jack S, Davidson MB, Einhorn D, Garvey WT, Grunberger G, Handelsman Y, Hirsch IB, Jellinger PS, McGill JB, Mechanick JI, Rosenblit PD, Umpierrez GE, Davidson MH. American Association of Clinical Endocrinologists' comprehensive diabetes management algorithm 2013 consensus statement--executive summary. Endocr Pract. 2013 May-Jun; 19(3):536-57. PMID: 23816937; PMCID: PMC4142590.
    33. Samson SL, Garber A. GLP-1R agonist therapy for diabetes: benefits and potential risks. Curr Opin Endocrinol Diabetes Obes. 2013 Apr; 20(2):87-97. PMID: 23403741.
      View in: PubMed
    34. Garber AJ. Methods to enhance delivery of prandial insulin and basal-prandial insulin. Diabetes Obes Metab. 2013 Mar; 15 Suppl 1:11-7. PMID: 23448198.
      View in: PubMed
    35. Garber AJ, Abrahamson MJ, Barzilay JI, Blonde L, Bloomgarden ZT, Bush MA, Dagogo-Jack S, Davidson MB, Einhorn D, Garvey WT, Grunberger G, Handelsman Y, Hirsch IB, Jellinger PS, McGill JB, Mechanick JI, Rosenblit PD, Umpierrez G, Davidson MH. AACE comprehensive diabetes management algorithm 2013. Endocr Pract. 2013 Mar-Apr; 19(2):327-36. PMID: 23598536.
      View in: PubMed
    36. Handelsman Y, Oral EA, Bloomgarden ZT, Brown RJ, Chan JL, Einhorn D, Garber AJ, Garg A, Garvey WT, Grunberger G, Henry RR, Lavin N, Tapiador CD, Weyer C. The clinical approach to the detection of lipodystrophy - an AACE consensus statement. Endocr Pract. 2013 Jan-Feb; 19(1):107-16. PMID: 23435042; PMCID: PMC4108221.
    37. Garber AJ, Blonde L, Bloomgarden ZT, Handelsman Y, Dagogo-Jack S. The role of bromocriptine-QR in the management of type 2 diabetes expert panel recommendations. Endocr Pract. 2013 Jan-Feb; 19(1):100-6. PMID: 23337160.
      View in: PubMed
    38. Mechanick JI, Garber AJ, Handlesman Y, Garvey WT, McMahon MM, Hurley DL. In response. Endocr Pract. 2013 Jan-Feb; 19(1):170. PMID: 24386668.
      View in: PubMed
    39. Plutzky J, Garber A, Falahati A, Toft AD, Poulter NR. Reductions in lipids and CV risk markers in patients with type 2 diabetes treated with liraglutide: a meta-analysis. Can J Diabetes. 2009; 33(3):209-10. PMID: 25998594.
      View in: PubMed
    40. Garber AJ, Repas T, Kruger DF, Alamia R. Building a solid foundation in diabetes: the nuts and bolts of insulin therapy. Am J Med. 2012 Nov; 125(11):S1-2. PMID: 23098875.
      View in: PubMed
    41. Bloomgarden ZT, Blonde L, Garber AJ, Wysham CH. Current issues in GLP-1 receptor agonist therapy for type 2 diabetes. Endocr Pract. 2012 Nov-Dec; 18 Suppl 3:6-26; quiz 27-8. PMID: 23315305.
      View in: PubMed
    42. Brooks MM, Chaitman BR, Nesto RW, Hardison RM, Feit F, Gersh BJ, Krone RJ, Sako EY, Rogers WJ, Garber AJ, King SB, Davidson CJ, Ikeno F, Frye RL. Clinical and angiographic risk stratification and differential impact on treatment outcomes in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial. Circulation. 2012 Oct 23; 126(17):2115-24. PMID: 23008442; PMCID: PMC4104411.
    43. Mechanick JI, Garber AJ, Handelsman Y, Garvey WT. American Association of Clinical Endocrinologists' position statement on obesity and obesity medicine. Endocr Pract. 2012 Sep-Oct; 18(5):642-8. PMID: 23047927.
      View in: PubMed
    44. Garber AJ. Postprandial dysmetabolism and the heart. Heart Fail Clin. 2012 Oct; 8(4):563-73. PMID: 22999240.
      View in: PubMed
    45. Pratley RE, Nauck MA, Bailey T, Montanya E, Filetti S, Garber AJ, Thomsen AB, Furber S, Davies M. Efficacy and safety of switching from the DPP-4 inhibitor sitagliptin to the human GLP-1 analog liraglutide after 52 weeks in metformin-treated patients with type 2 diabetes: a randomized, open-label trial. Diabetes Care. 2012 Oct; 35(10):1986-93. PMID: 22851600; PMCID: PMC3447855.
    46. Garber AJ. Hypoglycaemia: a therapeutic concern in type 2 diabetes. Lancet. 2012 Jun 16; 379(9833):2215-6. PMID: 22704156.
      View in: PubMed
    47. Garber AJ, King AB, Del Prato S, Sreenan S, Balci MK, Muñoz-Torres M, Rosenstock J, Endahl LA, Francisco AM, Hollander P. Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 2 diabetes (BEGIN Basal-Bolus Type 2): a phase 3, randomised, open-label, treat-to-target non-inferiority trial. Lancet. 2012 Apr 21; 379(9825):1498-507. PMID: 22521072.
      View in: PubMed
    48. Garber AJ. Current challenges in type 2 diabetes. Diabetes Obes Metab. 2012 Apr; 14 Suppl 2:1-3. PMID: 22405263.
      View in: PubMed
    49. Garber AJ. Liraglutide in oral antidiabetic drug combination therapy. Diabetes Obes Metab. 2012 Apr; 14 Suppl 2:13-9. PMID: 22405265.
      View in: PubMed
    50. Vilsbøll T, Garber AJ. Non-glycaemic effects mediated via GLP-1 receptor agonists and the potential for exploiting these for therapeutic benefit: focus on liraglutide. Diabetes Obes Metab. 2012 Apr; 14 Suppl 2:41-9. PMID: 22405268.
      View in: PubMed
    51. Garber AJ. Obesity and type 2 diabetes: which patients are at risk? Diabetes Obes Metab. 2012 May; 14(5):399-408. PMID: 22074144.
      View in: PubMed
    52. Garber AJ. Novel GLP-1 receptor agonists for diabetes. Expert Opin Investig Drugs. 2012 Jan; 21(1):45-57. PMID: 22111970.
      View in: PubMed
    53. Garber AJ. Incretin therapy--present and future. Rev Diabet Stud. 2011; 8(3):307-22. PMID: 22262069; PMCID: PMC3280666.
    54. Sharma MD, Farmer JA, Garber A. Type 2 diabetes and cardiovascular risk factors. Curr Med Res Opin. 2011 Nov; 27 Suppl 3:1-5. PMID: 22106974.
      View in: PubMed
    55. Garber AJ. Novel incretin-based agents and practical regimens to meet needs and treatment goals of patients with type 2 diabetes mellitus. J Am Osteopath Assoc. 2011 Jul; 111(7 Suppl 5):S20-30. PMID: 21813733.
      View in: PubMed
    56. Garber AJ. Incretin effects on ?-cell function, replication, and mass: the human perspective. Diabetes Care. 2011 May; 34 Suppl 2:S258-63. PMID: 21525465; PMCID: PMC3632189.
    57. Garber AJ. Long-acting glucagon-like peptide 1 receptor agonists: a review of their efficacy and tolerability. Diabetes Care. 2011 May; 34 Suppl 2:S279-84. PMID: 21525469; PMCID: PMC3632193.
    58. Garber A, Henry RR, Ratner R, Hale P, Chang CT, Bode B. Liraglutide, a once-daily human glucagon-like peptide 1 analogue, provides sustained improvements in glycaemic control and weight for 2 years as monotherapy compared with glimepiride in patients with type 2 diabetes. Diabetes Obes Metab. 2011 Apr; 13(4):348-56. PMID: 21205128; PMCID: PMC3084519.
    59. Garber AJ. Hypertension and lipid management in prediabetic states. J Clin Hypertens (Greenwich). 2011 Apr; 13(4):270-4. PMID: 21466625.
      View in: PubMed
    60. Buse JB, Garber A, Rosenstock J, Schmidt WE, Brett JH, Videbæk N, Holst J, Nauck M. Liraglutide treatment is associated with a low frequency and magnitude of antibody formation with no apparent impact on glycemic response or increased frequency of adverse events: results from the Liraglutide Effect and Action in Diabetes (LEAD) trials. J Clin Endocrinol Metab. 2011 Jun; 96(6):1695-702. PMID: 21450987.
      View in: PubMed
    61. Handelsman Y, Mechanick JI, Blonde L, Grunberger G, Bloomgarden ZT, Bray GA, Dagogo-Jack S, Davidson JA, Einhorn D, Ganda O, Garber AJ, Hirsch IB, Horton ES, Ismail-Beigi F, Jellinger PS, Jones KL, Jovanovi? L, Lebovitz H, Levy P, Moghissi ES, Orzeck EA, Vinik AI, Wyne KL. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for developing a diabetes mellitus comprehensive care plan. Endocr Pract. 2011 Mar-Apr; 17 Suppl 2:1-53. PMID: 21474420.
      View in: PubMed
    62. Pratley R, Nauck M, Bailey T, Montanya E, Cuddihy R, Filetti S, Garber A, Thomsen AB, Hartvig H, Davies M. One year of liraglutide treatment offers sustained and more effective glycaemic control and weight reduction compared with sitagliptin, both in combination with metformin, in patients with type 2 diabetes: a randomised, parallel-group, open-label trial. Int J Clin Pract. 2011 Apr; 65(4):397-407. PMID: 21355967; PMCID: PMC3085127.
    63. Handelsman Y, Mechanick JI, Blonde L, Grunberger G, Bloomgarden ZT, Bray GA, Dagogo-Jack S, Davidson JA, Einhorn D, Ganda O, Garber AJ, Hirsch IB, Horton ES, Ismail-Beigi F, Jellinger PS, Jones KL, Jovanovi? L, Lebovitz H, Levy P, Moghissi ES, Orzeck EA, Vinik AI, Wyne KL. American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for developing a diabetes mellitus comprehensive care plan: executive summary. Endocr Pract. 2011 Mar-Apr; 17(2):287-302. PMID: 21474421.
      View in: PubMed
    64. Garber AJ. Incretin-based therapies in the management of type 2 diabetes: rationale and reality in a managed care setting. Am J Manag Care. 2010 Aug; 16(7 Suppl):S187-94. PMID: 20809667.
      View in: PubMed
    65. Bode BW, Testa MA, Magwire M, Hale PM, Hammer M, Blonde L, Garber A. Patient-reported outcomes following treatment with the human GLP-1 analogue liraglutide or glimepiride in monotherapy: results from a randomized controlled trial in patients with type 2 diabetes. Diabetes Obes Metab. 2010 Jul; 12(7):604-12. PMID: 20590735; PMCID: PMC2901519.
    66. Mechanick JI, Camacho PM, Cobin RH, Garber AJ, Garber JR, Gharib H, Petak SM, Rodbard HW, Trence DL. American Association of Clinical Endocrinologists Protocol for Standardized Production of Clinical Practice Guidelines--2010 update. Endocr Pract. 2010 Mar-Apr; 16(2):270-83. PMID: 20350905.
      View in: PubMed
    67. Jendle J, Nauck MA, Matthews DR, Frid A, Hermansen K, Düring M, Zdravkovic M, Strauss BJ, Garber AJ. Weight loss with liraglutide, a once-daily human glucagon-like peptide-1 analogue for type 2 diabetes treatment as monotherapy or added to metformin, is primarily as a result of a reduction in fat tissue. Diabetes Obes Metab. 2009 Dec; 11(12):1163-72. PMID: 19930006.
      View in: PubMed
    68. Garber AJ. Restaging insulin therapy for patients with type 2 diabetes. Diabetes Obes Metab. 2009 Nov; 11 Suppl 5:1-5. PMID: 19817776.
      View in: PubMed
    69. Garber AJ. The importance of titrating starting insulin regimens in patients with type 2 diabetes. Diabetes Obes Metab. 2009 Nov; 11 Suppl 5:10-3. PMID: 19817778.
      View in: PubMed
    70. Garber AJ. Insulin intensification strategies in type 2 diabetes: when one injection is no longer sufficient. Diabetes Obes Metab. 2009 Nov; 11 Suppl 5:14-8. PMID: 19817779.
      View in: PubMed
    71. Nauck MA, Vilsbøll T, Gallwitz B, Garber A, Madsbad S. Incretin-based therapies: viewpoints on the way to consensus. Diabetes Care. 2009 Nov; 32 Suppl 2:S223-31. PMID: 19875556; PMCID: PMC2811437.
    72. Garber AJ. Combined pharmacologic/nonpharmacologic intervention in individuals at high risk of developing type 2 diabetes: pro pharmacologic therapy. Diabetes Care. 2009 Nov; 32 Suppl 2:S184-8. PMID: 19875549; PMCID: PMC2811461.
    73. Sharma MD, Garber AJ. What is the best treatment for prediabetes? Curr Diab Rep. 2009 Oct; 9(5):335-41. PMID: 19793502.
      View in: PubMed
    74. Rodbard HW, Jellinger PS, Davidson JA, Einhorn D, Garber AJ, Grunberger G, Handelsman Y, Horton ES, Lebovitz H, Levy P, Moghissi ES, Schwartz SS. Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control. Endocr Pract. 2009 Sep-Oct; 15(6):540-59. PMID: 19858063.
      View in: PubMed
    75. DeFronzo RA, Hissa MN, Garber AJ, Luiz Gross J, Yuyan Duan R, Ravichandran S, Chen RS. The efficacy and safety of saxagliptin when added to metformin therapy in patients with inadequately controlled type 2 diabetes with metformin alone. Diabetes Care. 2009 Sep; 32(9):1649-55. PMID: 19478198; PMCID: PMC2732156.
    76. Garber AJ, Handelsman Y, Einhorn D, Bergman DA, Bloomgarden ZT, Fonseca V, Garvey WT, Gavin JR, Grunberger G, Horton ES, Jellinger PS, Jones KL, Lebovitz H, Levy P, McGuire DK, Moghissi ES, Nesto RW. Diagnosis and management of prediabetes in the continuum of hyperglycemia: when do the risks of diabetes begin? A consensus statement from the American College of Endocrinology and the American Association of Clinical Endocrinologists. Endocr Pract. 2008 Oct; 14(7):933-46. PMID: 18996826.
      View in: PubMed
    77. Garber A, Henry R, Ratner R, Garcia-Hernandez PA, Rodriguez-Pattzi H, Olvera-Alvarez I, Hale PM, Zdravkovic M, Bode B. Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trial. Lancet. 2009 Feb 7; 373(9662):473-81. PMID: 18819705.
      View in: PubMed
    78. Garber AJ, Spann SJ. An overview of incretin clinical trials. J Fam Pract. 2008 Sep; 57(9 Suppl):S10-8. PMID: 18786339.
      View in: PubMed
    79. Sharma SK, Yeo JP, Garber A. Lessons in initiating insulin in clinical practice. Diabetes Res Clin Pract. 2008 Sep; 81 Suppl 1:S16-22. PMID: 18672308.
      View in: PubMed
    80. Sharma MD, Garber AJ, Farmer JA. Role of insulin signaling in maintaining energy homeostasis. Endocr Pract. 2008 Apr; 14(3):373-80. PMID: 18463047.
      View in: PubMed
    81. Garber AJ, Foley JE, Banerji MA, Ebeling P, Gudbjörnsdottir S, Camisasca RP, Couturier A, Baron MA. Effects of vildagliptin on glucose control in patients with type 2 diabetes inadequately controlled with a sulphonylurea. Diabetes Obes Metab. 2008 Nov; 10(11):1047-56. PMID: 18284434.
      View in: PubMed
    82. Garber AJ, Sharma MD. Update: vildagliptin for the treatment of Type 2 diabetes. Expert Opin Investig Drugs. 2008 Jan; 17(1):105-13. PMID: 18095923.
      View in: PubMed
    83. Garber AJ, Clauson P, Pedersen CB, Kølendorf K. Lower risk of hypoglycemia with insulin detemir than with neutral protamine hagedorn insulin in older persons with type 2 diabetes: a pooled analysis of phase III trials. J Am Geriatr Soc. 2007 Nov; 55(11):1735-40. PMID: 17979896.
      View in: PubMed
    84. Garber AJ, Ligthelm R, Christiansen JS, Liebl A. Premixed insulin treatment for type 2 diabetes: analogue or human? Diabetes Obes Metab. 2007 Sep; 9(5):630-9. PMID: 17697056.
      View in: PubMed
    85. Garber A. Response to Pokharna and Kanna: initial treatment with rosiglitazone/metformin fixed-dose combination therapy compared with monotherapy with either rosiglitazone or metformin in patients with uncontrolled type 2 diabetes. Diabetes Obes Metab. 2008 May; 10(5):436-7. PMID: 17596200.
      View in: PubMed
    86. Garber AJ, Schweizer A, Baron MA, Rochotte E, Dejager S. Vildagliptin in combination with pioglitazone improves glycaemic control in patients with type 2 diabetes failing thiazolidinedione monotherapy: a randomized, placebo-controlled study. Diabetes Obes Metab. 2007 Mar; 9(2):166-74. PMID: 17300592.
      View in: PubMed
    87. Bosi E, Camisasca RP, Collober C, Rochotte E, Garber AJ. Effects of vildagliptin on glucose control over 24 weeks in patients with type 2 diabetes inadequately controlled with metformin. Diabetes Care. 2007 Apr; 30(4):890-5. PMID: 17277036.
      View in: PubMed
    88. Davidson MH, Basile J, Garber AJ, Phillips RA. Reducing the risk of stroke through appropriate targets and treatments. Prev Cardiol. 2007; 10(4):215-21. PMID: 17917519.
      View in: PubMed
    89. Raskin PR, Hollander PA, Lewin A, Gabbay RA, Bode B, Garber AJ. Basal insulin or premix analogue therapy in type 2 diabetes patients. Eur J Intern Med. 2007 Jan; 18(1):56-62. PMID: 17223044.
      View in: PubMed
    90. Ray JA, Valentine WJ, Roze S, Nicklasson L, Cobden D, Raskin P, Garber A, Palmer AJ. Insulin therapy in type 2 diabetes patients failing oral agents: cost-effectiveness of biphasic insulin aspart 70/30 vs. insulin glargine in the US. Diabetes Obes Metab. 2007 Jan; 9(1):103-13. PMID: 17199725.
      View in: PubMed
    91. Rosenstock J, Rood J, Cobitz A, Huang C, Garber A. Improvement in glycaemic control with rosiglitazone/metformin fixed-dose combination therapy in patients with type 2 diabetes with very poor glycaemic control. Diabetes Obes Metab. 2006 Nov; 8(6):643-9. PMID: 17026488.
      View in: PubMed
    92. Rosenstock J, Rood J, Cobitz A, Biswas N, Chou H, Garber A. Initial treatment with rosiglitazone/metformin fixed-dose combination therapy compared with monotherapy with either rosiglitazone or metformin in patients with uncontrolled type 2 diabetes. Diabetes Obes Metab. 2006 Nov; 8(6):650-60. PMID: 17026489.
      View in: PubMed
    93. Garber A, Klein E, Bruce S, Sankoh S, Mohideen P. Metformin-glibenclamide versus metformin plus rosiglitazone in patients with type 2 diabetes inadequately controlled on metformin monotherapy. Diabetes Obes Metab. 2006 Mar; 8(2):156-63. PMID: 16448519.
      View in: PubMed
    94. Garber AJ. New standards to reduce morbidity and mortality in hospitalized patients with diabetes. Am Fam Physician. 2006 Feb 15; 73(4):591, 594. PMID: 16506704.
      View in: PubMed
    95. Gotto AM, Blackburn GL, Dailey GE, Garber AJ, Grundy SM, Sobel BE, Weir MR. The metabolic syndrome: a call to action. Coron Artery Dis. 2006 Feb; 17(1):77-80. PMID: 16374146.
      View in: PubMed
    96. Garber AJ, Wahlen J, Wahl T, Bressler P, Braceras R, Allen E, Jain R. Attainment of glycaemic goals in type 2 diabetes with once-, twice-, or thrice-daily dosing with biphasic insulin aspart 70/30 (The 1-2-3 study). Diabetes Obes Metab. 2006 Jan; 8(1):58-66. PMID: 16367883.
      View in: PubMed
    97. Garber AJ. Premixed insulin analogues for the treatment of diabetes mellitus. Drugs. 2006; 66(1):31-49. PMID: 16398567.
      View in: PubMed
    98. Vasudevan AR, Garber AJ. Diabetic dyslipidemia and the heart. Heart Fail Clin. 2006 Jan; 2(1):37-52. PMID: 17386875.
      View in: PubMed
    99. Garber AJ. Pharmacologic modifications of hormones to improve their therapeutic potential for diabetes management. Diabetes Obes Metab. 2005 Nov; 7(6):666-74. PMID: 16219010.
      View in: PubMed
    100. Vasudevan AR, Garber AJ. Insulin resistance syndrome. A review. Minerva Endocrinol. 2005 Sep; 30(3):101-19. PMID: 16208303.
      View in: PubMed
    101. Bryer-Ash M, Garber AJ. Point: Inpatient glucose management: the emperor finally has clothes. Diabetes Care. 2005 Apr; 28(4):973-5. PMID: 15793209.
      View in: PubMed
    102. Garber AJ. Cardiovascular risk and diabetes mellitus management: diagnosis and treatment in special patient populations. Introduction. Am J Med. 2005 Apr; 118 Suppl 2:1S-2S. PMID: 15903288.
      View in: PubMed
    103. Raskin P, Allen E, Hollander P, Lewin A, Gabbay RA, Hu P, Bode B, Garber A. Initiating insulin therapy in type 2 Diabetes: a comparison of biphasic and basal insulin analogs. Diabetes Care. 2005 Feb; 28(2):260-5. PMID: 15677776.
      View in: PubMed
    104. Garber AJ. Assessing the role of biphasic insulin aspart 30 as an effective and tolerable front-line therapy for type 2 diabetes. Clin Ther. 2005; 27 Suppl B:S39-41. PMID: 16519036.
      View in: PubMed
    105. Huang AJ, Gemperli MP, Bergthold L, Singer SS, Garber A. Health plans' coverage determinations for technology-based interventions: the case of electrical bone growth stimulation. Am J Manag Care. 2004 Dec; 10(12):957-62. PMID: 15617371.
      View in: PubMed
    106. Garber AJ. The metabolic syndrome. Med Clin North Am. 2004 Jul; 88(4):837-46, ix. PMID: 15308381.
      View in: PubMed
    107. Garber AJ, Moghissi ES, Bransome ED, Clark NG, Clement S, Cobin RH, Furnary AP, Hirsch IB, Levy P, Roberts R, Van den Berghe G, Zamudio V. American College of Endocrinology position statement on inpatient diabetes and metabolic control. Endocr Pract. 2004 Mar-Apr; 10 Suppl 2:4-9. PMID: 15251633.
      View in: PubMed
    108. Garber AJ, Seidel J, Armbruster M. Current standards of care for inpatient glycemic management and metabolic control: is it time for definite standards and targets? Endocr Pract. 2004 Mar-Apr; 10 Suppl 2:10-2. PMID: 15251634.
      View in: PubMed
    109. Goss JA, Goodpastor SE, Brunicardi FC, Barth MH, Soltes GD, Garber AJ, Hamilton DJ, Alejandro R, Ricordi C. Development of a human pancreatic islet-transplant program through a collaborative relationship with a remote islet-isolation center. Transplantation. 2004 Feb 15; 77(3):462-6. PMID: 14966428.
      View in: PubMed
    110. Garber AJ, Moghissi ES, Bransome ED, Clark NG, Clement S, Cobin RH, Furnary AP, Hirsch IB, Levy P, Roberts R, Van den Berghe G, Zamudio V. American College of Endocrinology position statement on inpatient diabetes and metabolic control. Endocr Pract. 2004 Jan-Feb; 10(1):77-82. PMID: 15251626.
      View in: PubMed
    111. Garber AJ. Metformin and vascular protection: a diabetologist's view. Diabetes Metab. 2003 Sep; 29(4 Pt 2):6S113-6. PMID: 14502108.
      View in: PubMed
    112. Garber AJ. Benefits of combination therapy of insulin and oral hypoglycemic agents. Arch Intern Med. 2003 Aug 11-25; 163(15):1781-2. PMID: 12912710.
      View in: PubMed
    113. Garber AJ, Donovan DS, Dandona P, Bruce S, Park JS. Efficacy of glyburide/metformin tablets compared with initial monotherapy in type 2 diabetes. J Clin Endocrinol Metab. 2003 Aug; 88(8):3598-604. PMID: 12915642.
      View in: PubMed
    114. Garber A, Marre M, Blonde L, Allavoine T, Howlett H, Lehert P, Cornes M. Influence of initial hyperglycaemia, weight and age on the blood glucose lowering efficacy and incidence of hypoglycaemic symptoms with a single-tablet metformin-glibenclamide therapy (Glucovance) in type 2 diabetes. Diabetes Obes Metab. 2003 May; 5(3):171-9. PMID: 12681024.
      View in: PubMed
    115. Garber AJ. Cardiovascular complications of diabetes: prevention and management. Clin Cornerstone. 2003; 5(2):22-37. PMID: 12800478.
      View in: PubMed
    116. Goss JA, Schock AP, Brunicardi FC, Goodpastor SE, Garber AJ, Soltes G, Barth M, Froud T, Alejandro R, Ricordi C. Achievement of insulin independence in three consecutive type-1 diabetic patients via pancreatic islet transplantation using islets isolated at a remote islet isolation center. Transplantation. 2002 Dec 27; 74(12):1761-6. PMID: 12499894.
      View in: PubMed
    117. Garber AJ, Bruce S, Fiedorek FT. Durability of efficacy and long-term safety profile of glyburide/metformin tablets in patients with type 2 diabetes mellitus: an open-label extension study. Clin Ther. 2002 Sep; 24(9):1401-13. PMID: 12380632.
      View in: PubMed
    118. Lee HJ, Choi SS, Park MK, An YJ, Seo SY, Kim MC, Hong SH, Hwang TH, Kang DY, Garber AJ, Kim DK. Fenofibrate lowers abdominal and skeletal adiposity and improves insulin sensitivity in OLETF rats. Biochem Biophys Res Commun. 2002 Aug 16; 296(2):293-9. PMID: 12163016.
      View in: PubMed
    119. Grundy SM, Garber A, Goldberg R, Havas S, Holman R, Lamendola C, Howard WJ, Savage P, Sowers J, Vega GL. Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group IV: lifestyle and medical management of risk factors. Circulation. 2002 May 7; 105(18):e153-8. PMID: 11994266.
      View in: PubMed
    120. Garber AJ, Larsen J, Schneider SH, Piper BA, Henry D. Simultaneous glyburide/metformin therapy is superior to component monotherapy as an initial pharmacological treatment for type 2 diabetes. Diabetes Obes Metab. 2002 May; 4(3):201-8. PMID: 12047399.
      View in: PubMed
    121. Garber AJ. Attenuating CV risk factors in patients with diabetes: clinical evidence to clinical practice. Diabetes Obes Metab. 2002 Jan; 4 Suppl 1:S5-12. PMID: 11843949.
      View in: PubMed
    122. Garber AJ, Karlsson FO. Treatment of dyslipidemia in diabetes. Endocrinol Metab Clin North Am. 2001 Dec; 30(4):999-1010. PMID: 11727408.
      View in: PubMed
    123. Glanz M, Garber AJ, Mancia G, Levenstein M. Meta-analysis of studies using selective alpha1-blockers in patients with hypertension and type 2 diabetes. Int J Clin Pract. 2001 Dec; 55(10):694-701. PMID: 11777296.
      View in: PubMed
    124. Basa AL, Garber AJ. Cardiovascular disease and diabetes: modifying risk factors other than glucose control. Ochsner J. 2001 Jul; 3(3):132-7. PMID: 22754389; PMCID: PMC3385778.
    125. Garber AJ. Attenuating cardiovascular risk factors in patients with type 2 diabetes. Am Fam Physician. 2000 Dec 15; 62(12):2633-42, 2645-6. PMID: 11142470.
      View in: PubMed
    126. Garber AJ. Diabetes and vascular disease. Diabetes Obes Metab. 2000 Nov; 2 Suppl 2:S1-5. PMID: 11210239.
      View in: PubMed
    127. Garber AJ. Implications of cardiovascular risk in patients with type 2 diabetes who have abnormal lipid profiles: is lower enough? Diabetes Obes Metab. 2000 Oct; 2(5):263-70. PMID: 11225741.
      View in: PubMed
    128. Garber AJ. The importance of early insulin secretion and its impact on glycaemic regulation. Int J Obes Relat Metab Disord. 2000 Sep; 24 Suppl 3:S32-7. PMID: 11063282.
      View in: PubMed
    129. Garber AJ. Using dose-response characteristics of therapeutics agents for treatment decisions in type 2 diabetes. Diabetes Obes Metab. 2000 Jun; 2(3):139-47. PMID: 11220549.
      View in: PubMed
    130. Garber AJ. Strategies for better diabetes control in the US. Drugs. 1999; 58 Suppl 1:61-9. PMID: 10576528.
      View in: PubMed
    131. Garber AJ. Vascular disease and lipids in diabetes. Med Clin North Am. 1998 Jul; 82(4):931-48. PMID: 9706127.
      View in: PubMed
    132. Krakow D, Reinker K, Powell B, Cantor R, Priore MA, Garber A, Lachman RS, Rimoin DL, Cohn DH. Localization of a multiple synostoses-syndrome disease gene to chromosome 17q21-22. Am J Hum Genet. 1998 Jul; 63(1):120-4. PMID: 9634519; PMCID: PMC1377242.
    133. Horvit PK, Garber AJ. Diabetes and atherosclerosis: mechanisms and management. Endocr Pract. 1998 Mar-Apr; 4(2):112-9. PMID: 15251756.
      View in: PubMed
    134. Garber AJ, Duncan TG, Goodman AM, Mills DJ, Rohlf JL. Efficacy of metformin in type II diabetes: results of a double-blind, placebo-controlled, dose-response trial. Am J Med. 1997 Dec; 103(6):491-7. PMID: 9428832.
      View in: PubMed
    135. Davidson JA, Einhorn D, Allweiss P, Flood TM, Garber AJ, Garcia MJ, Kahn CB, Soler NG, White Jr JR, Huster WJ. Effect of premixed nph and regular insulin on glucose control and health-related quality of life in patients with type 2 diabetes mellitus. Endocr Pract. 1997 Nov-Dec; 3(6):331-6. PMID: 15251769.
      View in: PubMed
    136. Garber AJ. Metformin: mechanisms of antihyperglycemic action, other pharmacodynamic properties, and safety perspectives. Endocr Pract. 1997 Nov-Dec; 3(6):359-70. PMID: 15251775.
      View in: PubMed
    137. Davidson JA, Garber AJ, DiMarchi RD, Santiago JV. New advances in insulin treatment of diabetes: overcoming barriers. Endocr Pract. 1997 Nov-Dec; 3(6):371-84. PMID: 15251776.
      View in: PubMed
    138. Garber AJ. Dyslipidemia as a risk factor for coronary disease in patients with diabetes. Endocr Pract. 1997 Jul-Aug; 3(4):244-7. PMID: 15251799.
      View in: PubMed
    139. Garber AJ. Standards of care for diabetes management reduce complications. Tex Med. 1996 Nov; 92(11):23. PMID: 8942285.
      View in: PubMed
    140. Karlsson FO, Garber AJ. Prevention and treatment of diabetic nephropathy: role of angiotensin-converting enzyme inhibitors. Endocr Pract. 1996 May-Jun; 2(3):215-9. PMID: 15251544.
      View in: PubMed
    141. Garber AJ. Magnesium utilization survey in selected patients with diabetes. Clin Ther. 1996 Mar-Apr; 18(2):285-94. PMID: 8733989.
      View in: PubMed
    142. Garber AJ. Clinical perspectives on type 2 diabetes in North America. Diabetes Metab Rev. 1995 Sep; 11 Suppl 1:S81-6. PMID: 8529489.
      View in: PubMed
    143. Garber A. The effect of intensive treatment of diabetes mellitus. N Engl J Med. 1994 Mar 3; 330(9):641-2. PMID: 8302353.
      View in: PubMed
    144. Garber AJ. Regression of atherosclerosis. Curr Ther Endocrinol Metab. 1994; 5:484-91. PMID: 7704778.
      View in: PubMed
    145. Bacino CA, Platt LD, Garber A, Carlson D, Pepkowitz S, Lachman RS, Sharony R, Rimoin DL, Graham JM. Fetal akinesia/hypokinesia sequence: prenatal diagnosis and intra-familial variability. Prenat Diagn. 1993 Nov; 13(11):1011-9. PMID: 8140062.
      View in: PubMed
    146. Garber AJ. Diabetes and heart disease: a new strategy for managing lipid disorders. Geriatrics. 1993 Oct; 48(10):34-6, 39-41. PMID: 8406050.
      View in: PubMed
    147. Kim DK, Escalante DA, Garber AJ. Prevention of atherosclerosis in diabetes: emphasis on treatment for the abnormal lipoprotein metabolism of diabetes. Clin Ther. 1993 Sep-Oct; 15(5):766-78; discussion 765. PMID: 8269443.
      View in: PubMed
    148. Garber AJ. Effective treatment of hypertension in patients with diabetes mellitus. Clin Cardiol. 1992 Oct; 15(10):715-9. PMID: 1356676.
      View in: PubMed
    149. Garber AJ, Vinik AI, Crespin SR. Detection and management of lipid disorders in diabetic patients. A commentary for clinicians. Diabetes Care. 1992 Aug; 15(8):1068-74. PMID: 1303635.
      View in: PubMed
    150. Garber AJ, Davidson JA, Krosnick A, Beaser RS, Anderson JH. Impact of transfer from animal-source insulins to biosynthetic human insulin (rDNA E coli) in patients with diabetes mellitus. Clin Ther. 1991 Sep-Oct; 13(5):627-36. PMID: 1799920.
      View in: PubMed
    151. Huffman DM, Garber AJ. Availability of soluble insulin in mixed preparations of crystalline and ultralente biosynthetic human insulin. Clin Ther. 1991 Mar-Apr; 13(2):232-8. PMID: 1863938.
      View in: PubMed
    152. Jankovic J, Grossman R, Goodman C, Pirozzolo F, Schneider L, Zhu Z, Scardino P, Garber AJ, Jhingran SG, Martin S. Clinical, biochemical, and neuropathologic findings following transplantation of adrenal medulla to the caudate nucleus for treatment of Parkinson's disease. Neurology. 1989 Sep; 39(9):1227-34. PMID: 2475820.
      View in: PubMed
    153. May ME, Lim-Abrahan MA, Brown I, Garber AJ. Hyporeninemic hypoaldosteronism. New associations. Arch Intern Med. 1985 Aug; 145(8):1519. PMID: 3896183.
      View in: PubMed
    154. Dighe RR, Rojas FJ, Birnbaumer L, Garber AJ. Glucagon-stimulable adenylyl cyclase in rat liver. Effects of chronic uremia and intermittent glucagon administration. J Clin Invest. 1984 Apr; 73(4):1004-12. PMID: 6323531; PMCID: PMC425113.
    155. Dighe RR, Rojas FJ, Birnbaumer L, Garber AJ. Glucagon-stimulable adenylyl cyclase in rat liver. The impact of streptozotocin-induced diabetes mellitus. J Clin Invest. 1984 Apr; 73(4):1013-23. PMID: 6323532; PMCID: PMC425114.
    156. Rojas FJ, Swartz TL, Iyengar R, Garber AJ, Birnbaumer L. Monoiodoglucagon: synthesis, purification by high pressure liquid chromatography, and characteristics as a receptor probe. Endocrinology. 1983 Aug; 113(2):711-9. PMID: 6307649.
      View in: PubMed
    157. Mather SR, Garber AJ, Attar M, Silvers A, Lawrie GM, Morris GC. Managing cardiac disease in patients with diabetes mellitus. Geriatrics. 1983 Apr; 38(4):81-2, 87-90. PMID: 6339327.
      View in: PubMed
    158. Arem R, Garber AJ, Field JB. Sulfonamide-induced hypoglycemia in chronic renal failure. Arch Intern Med. 1983 Apr; 143(4):827-9. PMID: 6340631.
      View in: PubMed
    159. Birnbaumer L, Swartz TL, Rojas FJ, Garber AJ. Synthesis, purification by HPLC and characterization of monoiodoglucagon labeled with carrier free 125I: use as glucagon receptor probe. J Recept Res. 1983; 3(1-2):3-20. PMID: 6304305.
      View in: PubMed
    160. Keenan BS, Kirland RT, Garber AJ, Rubenstein AH, Holcombe JH, Potts VE, Clayton GW. The effect of diet upon carbohydrate metabolism, insulin resistance, and blood pressure in congenital total lipoatrophic diabetes. Metabolism. 1980 Dec; 29(12):1214-24. PMID: 7005617.
      View in: PubMed
    161. Garber AJ. The impact of streptozotocin-induced diabetes mellitus on cyclic nucleotide regulation of skeletal muscle amino acid metabolism in the rat. J Clin Invest. 1980 Feb; 65(2):478-87. PMID: 6243311; PMCID: PMC371386.
    162. Kakvan M, Garber AJ. An overview of the current status of islet cell transplantation as a treatment for diabetes mellitus. Islet cell transplantation, artificial pancreas, or genetic insulin synthesis offer possibilities for physiologic glucose regulation. R I Med J. 1979 Sep; 62(9):361-6. PMID: 115077.
      View in: PubMed
    163. Gunning RR, Garber AJ. Bioactivity of instant glucose. Failure of absorption through oral mucosa. JAMA. 1978 Oct 6; 240(15):1611-2. PMID: 691147.
      View in: PubMed
    164. Garber AJ, Cryer PE, Santiago JV, Haymond MW, Pagliara AS, Kipnis DM. The role of adrenergic mechanisms in the substrate and hormonal response to insulin-induced hypoglycemia in man. J Clin Invest. 1976 Jul; 58(1):7-15. PMID: 6491; PMCID: PMC333149.
    165. Cryer PE, Garber AJ, Hoffsten P, Lucas B, Wise L. Renal failure after small intestinal bypass for obesity. Arch Intern Med. 1975 Dec; 135(12):1610-2. PMID: 1200730.
      View in: PubMed
    166. Garber AJ, Bier DM, Cryer PE, Pagliara AS. Hypoglycemia in compensated chronic renal insufficiency. Substrate limitation of gluconeogenesis. Diabetes. 1974 Dec; 23(12):982-6. PMID: 4435312.
      View in: PubMed
    167. Hanson RW, Garber AJ, Reshef L, Ballard FJ. Phosphoenolpyruvate carboxykinase. II. Hormonal controls. Am J Clin Nutr. 1973 Jan; 26(1):55-63. PMID: 4345515.
      View in: PubMed
    GARBER's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _